Brian Ritchie | IR, LifeSci Advisors |
Dr. Roger Crystal | CEO |
David O'Toole | CFO |
David Bautz | Zacks Investment Research |
Greetings and welcome to the Opiant’s Pharmaceuticals Fourth Quarter and Full Year 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Brian Ritchie of LifeSci Advisors.